Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant.
about
Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Ledipasvir/sofosbuvir without ...... fection post-liver transplant.
@en
Ledipasvir/sofosbuvir without ...... fection post-liver transplant.
@nl
type
label
Ledipasvir/sofosbuvir without ...... fection post-liver transplant.
@en
Ledipasvir/sofosbuvir without ...... fection post-liver transplant.
@nl
prefLabel
Ledipasvir/sofosbuvir without ...... fection post-liver transplant.
@en
Ledipasvir/sofosbuvir without ...... fection post-liver transplant.
@nl
P2093
P2860
P1476
Ledipasvir/sofosbuvir without ...... fection post-liver transplant.
@en
P2093
DeAnn Jones
Jordan Orr
Krishna Venkata
Mohamed Shoreibah
Omar Massoud
P2860
P2888
P356
10.1007/S12072-016-9778-6
P577
2017-01-12T00:00:00Z